Bison Wealth, LLC Gilead Sciences, Inc. Transaction History

Bison Wealth, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $218,984 - $249,782	2,881 New	2,881 $222,000
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $236,352 - $297,172	-3,806 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $795 - $924	-11 Reduced 0.29%	3,806 $293,000
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $34,321 - $43,960	-548 Reduced 12.55%	3,817 $285,000
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $14,542 - $15,996	-236 Reduced 5.13%	4,365 $284,000
Q3 2019 Nov 04, 2019	BUY	$62.51 - $69.0 $2,437 - $2,691	39 Added 0.85%	4,601 $292,000
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $45,474 - $50,994	735 Added 19.21%	4,562 $308,000
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $99,985 - $112,009	-1,599 Reduced 29.47%	3,827 $249,000
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $127,805 - $141,503	1,793 Added 49.35%	5,426 $419,000
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $53,071 - $61,906	-818 Reduced 18.38%	3,633 $257,000
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $27,460 - $33,477	-377 Reduced 7.81%	4,451 $336,000
Q4 2017 Jan 29, 2018	BUY	$71.15 - $83.52 $22,839 - $26,809	321 Added 7.12%	4,828 $346,000
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $324,999 - $385,213	4,507	4,507 $365,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Bison Wealth, LLC with notifications on news.